Back to search

Article

A Safe and Effective Mucosal RSV Vaccine Consisting of RSV Phosphoprotein and Flagellin Variant

2021-02-10

Abstract excerpt

<h4>SUMMARY</h4> Respiratory syncytial virus (RSV) is a major cause of serious acute lower respiratory tract infection in infants and the elderly. No licensed RSV vaccine available thus far calls for the development of vaccines with new target(s) and vaccination strategies. Here, we constructed a recombinant protein, designated P-KFD1, comprised of RSV phosphoprotein (P) and E. coli K12 strain-derived flagellin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
27b0c27f-100b-599f-989f-68fd1f2cc836
DOI
10.1101/2021.02.09.430425
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Safe and Effective Mucosal RSV Vaccine Consisting of RSV Phosphoprotein and Flagellin VariantDOI 10.1101/2021.02.09.430425
Select a neighboring publication to make it the new centre.